Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444067 · ClinicalTrials.gov registry record · NA
Study to Evaluate Safety & Effectiveness of Spinal Sealant
A NA study of Cerebrospinal Fluid Leakage, Subdural, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT00444067 is a NA study of Cerebrospinal Fluid Leakage, Subdural that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 98 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00444067, a NA study of Cerebrospinal Fluid Leakage, Subdural, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate a spinal sealant as an adjunct to sutured dural repair compared to standard of care techniques.
Conditions Studied
Interventions
- OTHER Standard of Care
- DEVICE Spinal Sealant
Study Locations (1)
Massachusetts
- Confluent Surgical, Inc. - Bedford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00444067
The ClinicalTrials.gov registry entry for NCT00444067 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cerebrospinal Fluid Leakage, Subdural appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT00444067 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00444067 about?
NCT00444067 is a clinical study titled "Study to Evaluate Safety & Effectiveness of Spinal Sealant". To evaluate a spinal sealant as an adjunct to sutured dural repair compared to standard of care techniques.
What is the current status of trial NCT00444067?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2007-05. Estimated completion is 2009-08.
What conditions does trial NCT00444067 study?
This clinical trial studies the following conditions: Cerebrospinal Fluid Leakage, Subdural.
What interventions are being tested in trial NCT00444067?
The interventions under investigation include: Standard of Care (OTHER), Spinal Sealant (DEVICE).
Who is sponsoring clinical trial NCT00444067?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00444067 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.